Ontology highlight
ABSTRACT:
SUBMITTER: Malik P
PROVIDER: S-EPMC3917925 | biostudies-literature | 2014
REPOSITORIES: biostudies-literature
Malik Priya P Cashen Amanda F AF
Cancer management and research 20140203
The majority of patients with acute myeloid leukemia (AML) are elderly and have a poor prognosis despite induction therapy. Decitabine, a DNA-hypomethylating agent that induces differentiation and apoptosis of leukemic cells, is a well-tolerated alternative to aggressive chemotherapy. It is currently FDA-approved for myelodysplastic syndrome, including patients with 20%-30% bone marrow blasts. Recent clinical attention has focused on evaluating decitabine as frontline therapy for untreated high- ...[more]